Wall Street analyst estimates for Simulations Plus, Inc. (SLP): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Simulations Plus, Inc. (SLP) is a worldwide developer of sophisticated software and services aimed at enhancing drug discovery and development processes. The company employs artificial intelligence and machine learning technologies to create tools for modeling, simulation, and predicting molecular characteristics. Its operations are divided into four main business units: Simulations Plus, Cognigen, DILIsym, and Lixoft.
Valuation Ratios
| P/E Ratio | 44.95 |
| Price / Book | 2.67 |
| EV / EBITDA | 17.32 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.0M | $24.1M | $29.7M | $34.0M | $41.6M | $46.5M | $53.9M | $59.6M | $70.0M | $79.2M |
| Cost of Revenue | $4.6M | $6.3M | $8.0M | $9.0M | $10.6M | $10.6M | $10.8M | $11.6M | $26.9M | $33.0M |
| Gross Profit | $15.4M | $17.8M | $21.7M | $24.9M | $30.9M | $35.9M | $43.1M | $47.9M | $43.2M | $46.2M |
| Research & Development | $1.4M | $1.4M | $1.8M | $2.5M | $3.0M | $4.0M | $3.2M | $4.5M | $5.8M | $6.9M |
| Selling, General & Admin | $6.7M | $8.2M | $9.6M | $11.8M | $16.4M | $20.6M | $25.0M | $34.7M | $31.3M | $32.8M |
| Operating Expenses | $8.1M | $9.6M | $11.4M | $14.3M | $19.3M | $24.6M | $28.2M | $39.2M | $37.0M | $117.0M |
| Operating Income | $7.2M | $8.3M | $10.3M | $10.6M | $11.6M | $11.3M | $14.9M | $8.7M | $6.1M | -$70.7M |
| EBITDA | $9.2M | $10.4M | $13.0M | $13.3M | $14.3M | $14.7M | $18.7M | $13.1M | $18.1M | $14.7M |
| Interest Expense | 0 | $38188 | 0 | 0 | 0 | $22000 | 0 | 0 | 0 | 0 |
| Pre-tax Income | $7.2M | $8.2M | $10.1M | $10.6M | $11.4M | $11.1M | $15.1M | $11.7M | $12.4M | -$69.4M |
| Income Tax | $2.3M | $2.5M | $1.2M | $2.0M | $2.1M | $1.3M | $2.6M | $1.7M | $2.5M | -$4.7M |
| Net Income | $5.0M | $5.8M | $8.9M | $8.6M | $9.3M | $9.8M | $12.5M | $10.0M | $10.0M | -$64.7M |
| EPS | $0.29 | $0.34 | $0.52 | $0.49 | $0.52 | $0.49 | $0.62 | $0.50 | $0.50 | $-3.22 |
| EPS (Diluted) | $0.29 | $0.33 | $0.50 | $0.48 | $0.50 | $0.47 | $0.60 | $0.49 | $0.49 | $-3.22 |
| Shares Outstanding (Diluted) | $17.2M | $17.5M | $17.9M | $18.1M | $18.5M | $20.7M | $20.7M | $20.5M | $20.3M | $20.1M |
Price
| Price | $18.43 |
| Market Cap | $373M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ACIU · AGL · ANRO · CLLS · DH · KRRO · NAKA
Explore sector: Technology · Software - Application
More sections of SLP: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks